China Kidney Preservation Market

China Kidney Preservation Market Insights Forecasts to 2035

• China Kidney Preservation Market Size 2024: USD 4.1 Million
• China Kidney Preservation Market Size 2035: USD 10.5 Million
• China Kidney Preservation Market CAGR 2024: 8.93%
• China Kidney Preservation Market Segments: Preservation Solution and Technique

The kidney preservation market is the steadily expanding market which is now transitioning from basic cold storages solutions towards the advanced hypothermic and the normothermic machine perfusion technologies. The growth for this market is driven by the organ transplant volumes, increasing the chronic kidney disease prevalence, and the expanding transplant infrastructure. Intense competition exists between domestic manufacturers and multinational firms amid NMPA regulatory reforms, centralized procurement, and pricing pressures. The increasing use of machine perfusion systems, enhanced preservation methods, and digital monitoring technologies is boosting innovation. In addition, localization of manufacturing, government support for transplant medicine, and increasing clinical research collaborations are enhancing cost efficiency and strengthening China’s presence in the global kidney preservation market.

 

China’s Chronic Kidney Disease (CKD) prevention efforts, including the China Kidney Disease Network (CK-NET), focus on tracking disease trends, improving early diagnosis, and promoting standardized management strategies. These initiatives aim to reduce progression to end-stage renal disease, indirectly supporting long-term kidney preservation and transplant demand management.

 

The China kidney preservation market shows strong growth potential, which is driven by the rising organ transplant volume, an increase in the chronic kidney disease prevalence, and the expanding transplant infrastructure. There are various advancements in the machine perfusion technologies, improvement in the preservation solution, and real time organ monitoring that are now boosting the demand for a higher quality preservation system. Emerging opportunities include normothermic and hypothermic perfusion devices, AI-enabled monitoring, and extended organ viability solutions, supported by domestic manufacturing upgrades, government backing for transplant medicine, regulatory reforms, and growing hospital and organ-sharing network expansion across China.

 

Market Dynamics of the China Kidney Preservation Market

The Chinese kidney preservation market is driven by a rapidly aging population, with the rising chronic kidney disease incidence, increasing organ transplant demand, and the strong government support for transplant medicine and healthcare infrastructure. Expanding transplant centers, improved organ-sharing networks, and the growing R&D capabilities are shifting the market from basic cold storage toward advanced machine perfusion and optimized preservation solutions. Large patient populations and transplant volumes help to validate new technologies, while rising healthcare investment and localization policies promote domestic innovation, cost efficiency, and export growth, establishing China as an emerging player in the global kidney preservation landscape.

 

The Chinese kidney preservation market is constrained by strict government pricing controls, complex and evolving NMPA regulatory requirements, and intellectual property protection challenges. Dependence on imported advanced machine perfusion systems and preservation solutions, limited clinical standardization, and shortages of specialized transplant technology expertise further restrict domestic innovation and profitability despite rising transplant demand.

 

The future of the Chinese kidney preservation market is bright and promising, driven by rising organ transplant volumes, expanding transplant center infrastructure, and growing awareness of organ quality and utilization. Government support for domestic medical-device innovation, increased adoption of machine perfusion technologies, advances in preservation solutions and real-time monitoring, wider use of automation and smart manufacturing, integration of digital transplant management platforms, and expansion of clinical training programs are enhancing preservation outcomes, technology adoption, and overall market growth across China.

 

Market Segmentation

The China Kidney Preservation Market share is classified into preservation solutions and techniques

 

By Preservation Solution

The Chinese kidney preservation market is divided by preservation solution into the University of Wisconsin solution the Celsior solution. Among these, the University of Wisconsin solution segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is because the UW solution is one of the first preservation fluids to significantly improve transplant outcomes and extend storage times, leading to its status as the "gold standard" for intra-abdominal organ preservation globally and in China.

 

By Technique

The China kidney preservation market is divided by technique into normothermic machine perfusion, hypothermic machine perfusion. Among these, the normothermic machine perfusion segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. It is because NMP preserves the kidney at a near-physiological temperature (35-37 °C), which allows the organ to remain metabolically active and minimizes damage from cold ischemia.

 

Competitive Analysis

The report offers the appropriate analysis of the key organisations/companies involved within the China kidney preservation market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Key Companies in the China Kidney Preservation Market

• Institut Georges Lopez (IGL
• Essential Pharmaceuticals LLC
• Paragonix Technologies Inc.
• TransMedics Inc.
• Shanghai Genext Medical Technology Co., Ltd
• Dr. Franz Köhler Chemie GmbH
• Bridge to Life Ltd
• Organ Recovery Systems
• Preservation Solutions Inc
• Others

 

Recent Developments in the China Kidney Preservation Market

In May 2024, Everest Medicines launched NEFECON® in mainland China, the first approved oral therapy for primary IgA nephropathy, providing an early treatment option to slow kidney function decline and improve outcomes for young Chinese adults.

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the China, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the Chinese kidney preservation market based on the following segments:

 

China Kidney Preservation Market, By Preservation Solution

• University of Wisconsin Solution
• Celsior Solution

 

China Kidney Preservation Market, By Technique

• Normothermic Machine Perfusion
• Hypothermic Machine Perfusion

 

FAQ

Q: What is the China kidney preservation market size?

A: China's kidney preservation market is expected to grow from USD 4.1 million in 2024 to USD 10.5 million by 2035, growing at a CAGR of 8.93% during the forecast period 2025-2035.

 

Q: What are the key growth drivers of the market?

A: Market growth is driven by a rapidly aging population, with the rising chronic kidney disease incidence, increasing organ transplant demand, and the strong government support for transplant medicine and healthcare infrastructure.

 

Q: What factors restrain the Chinese kidney preservation market?

A: Constraints include the strict government pricing controls, complex and evolving NMPA regulatory requirements, and intellectual property protection challenges.

 

Q: How is the market segmented by preservation solution?

A: The market is segmented into University of Wisconsin solution the Celsior solution.

 

Q: Who are the key players in the Chinese kidney preservation market?

A: Key companies include Institut Georges Lopez, Essential Pharmaceuticals LLC, Paragonix Technologies Inc., TransMedics Inc., Shanghai Genext Medical Technology Co., Ltd, Dr. Franz Köhler Chemie GmbH, Bridge to Life Ltd, Organ Recovery Systems, Preservation Solutions Inc, and Others.

 

Q: Who are the target audiences for this market report?

A: The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).